Intellectual property and technology law is complex and rapidly evolving. Whether your chief concern is patents, trade secrets, designs, or protecting your brand, success often depends on getting the best strategic advice and deploying that advice rapidly and efficiently.
Please join DLA Piper and our panel of in-house counsel to learn about timely intellectual property issues facing technology and life sciences companies.
Kerry Flynn, Vice President, Chief IP Counsel, Vertex Pharmaceuticals
Shirley Paley, General Counsel, Catalant
Robert Silverman, Ph.D. Senior Vice President and General Counsel, Concert Pharmaceuticals
Jason P. Fiorillo, Vice President, Intellectual Property and Commercial Matters, Analog Devices, Inc.
FOR MORE INFORMATION
Please contact Jaime Novack